RevitalVision vision-training software
Digital Health News

Groundbreaking Study by Dr. Agarwal’s Eye Hospital on post-crosslinking surgery patients Wins ‘Best Scientific Poster Award’ at ASCRS 2024 Annual Meeting

Dr Agarwal’s Eye Hospital recently announced that their accomplished research team have been honoured with the prestigious ‘Best Scientific Poster Award’ at the 2024 Annual Meeting of the American Society for Cataract and Refractive Surgery (ASCRS). This recognition comes in light of their groundbreaking study on ‘The efficacy of RevitalVision vision-training software in improving best-corrected […]

"Illustration depicting ankle replacement surgery"
Device Digest

Father of Exactech Employee Receives First Ankle Replacement Using Activit-E™ Polyethylene

Exactech Quality Control Manager Wesley Garrett experienced a full circle moment in both his professional and personal life when his father received an Activit-E™ polyethylene insert after following the company’s polyethylene initiatives for six years.  In 2018, Garrett was hired as an intern to perform wear-testing for the company’s hip product line. Specifically, he tested results between vitamin E-infused […]

Recognized as Top Imaging Vendor in KLAS Research Report
Device Digest

Medicom Recognized as One of the Most Promising Health IT Imaging Vendors of 2024 by KLAS Research

Medicom Technologies, Inc. (Medicom) proudly announces its recognition as one of the most promising IT vendors in Imaging in the Emerging HCIT Companies 2024 KLAS Research report. In a recent report released on January 16th, 2024, KLAS Research showcased Medicom alongside other healthcare IT vendors across various market segments. KLAS Research conducts annual interviews with healthcare organizations to assess their experiences […]

Ascentage Pharma Olverembatinib NCCN Guidelines CML Treatment
Drug Updates

Olverembatinib Included in Newest Guidelines on Chronic Myeloid Leukemia (CML) Management from the National Comprehensive Cancer Network (NCCN)

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that olverembatinib (R&D Code: HQP1351) has been included in the latest guidelines from the National Comprehensive Cancer Network (NCCN) for the management of  Chronic Myeloid Leukemia (CML),[1] marking a major development in global […]

Sectra Amplifier Services Enhances AI Adoption at Trillium Health Partners
Device Digest

Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement via Sectra Amplifier Services. This will enable THP to introduce AI-powered workflows in its diagnostic imaging department, which will help identify serious health conditions sooner, allowing for earlier intervention and better health outcomes. The Sectra […]

TekniPlex Healthcare Acquires Seisa Medical
Device Digest

TekniPlex Healthcare Signs Definitive Purchase Agreement To Acquire Seisa Medical

TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, has signed a definitive agreement to acquire Seisa Medical in a deal that significantly extends TekniPlex Healthcare’s medical technology solutions platform. This acquisition specifically enhances the company’s materials science and process technologies for minimally invasive and interventional therapy devices on a […]

TAR-210 Phase 1 Study Results
Drug Updates

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from an open-label, multicenter Phase 1 study evaluating the safety and efficacy of TAR-210, an intravesical delivery system designed to provide sustained, local release of erdafitinib into the bladder in patients with non-muscle-invasive bladder cancer (NMIBC) with select fibroblast growth factor receptor (FGFR) […]

SciBase and Bare Dermatology Collaboration
Hospital Updates

SciBase initiates pilot with Bare Dermatology to advance skin cancer detection in Texas

SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders announced today that they have entered into a collaboration agreement with Bare Dermatology to pilot Nevisense in select locations in Texas. Bare Dermatology is a dermatology practice group in the Greater Dallas area, with five offices and a team of […]

Digital Health News

New drug class prevents key ageing mechanism in organ transplants

A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of senescence, a key mechanism of ageing, in recipients of older donor organs. The pioneering research, presented today at the European Society for Organ Transplantation (ESOT) Congress 2023, opens promising avenues for expanding the organ donor […]

Drug Updates

Lung Cancer Research Foundation Announces Research Advocates

The Lung Cancer Research Foundation (LCRF) is pleased to announce the appointment of a select group of volunteers as its Research Advocates. These dedicated individuals are patients, survivors, caregivers, healthcare professionals, and advocates committed to identifying and funding innovative lung cancer research. This group is tasked with playing a significant role in determining areas of […]